Mass Production of Virus-Like Particles Using Chloroplast Genetic Engineering for Highly Immunogenic Oral Vaccine Against Fish Disease
- PMID: 34497627
- PMCID: PMC8419230
- DOI: 10.3389/fpls.2021.717952
Mass Production of Virus-Like Particles Using Chloroplast Genetic Engineering for Highly Immunogenic Oral Vaccine Against Fish Disease
Abstract
Nervous necrosis virus (NNV) is the causative agent of viral nervous necrosis (VNN), which is one of the most serious fish diseases leading to mass mortality in a wide range of fish species worldwide. Although a few injectable inactivated vaccines are commercially available, there is a need for more labor-saving, cost-effective, and fish-friendly immunization methods. The use of transgenic plants expressing pathogen-derived recombinant antigens as edible vaccines is an ideal way to meet these requirements. In this study, chloroplast genetic engineering was successfully utilized to overexpress the red-spotted grouper NNV capsid protein (RGNNV-CP). The RGNNV-CP accumulated at high levels in all young, mature, and old senescent leaves of transplastomic tobacco plants (averaging approximately 3 mg/g leaf fresh weight). The RGNNV-CP efficiently self-assembled into virus-like particles (RGNNV-VLPs) in the chloroplast stroma of the transgenic lines, which could be readily observed by in situ transmission electron microscopy. Furthermore, intraperitoneal injection and oral administration of the crudely purified protein extract containing chloroplast-derived RGNNV-VLPs provided the sevenband grouper fish with sufficient protection against RGNNV challenge, and its immunogenicity was comparable to that of a commercial injectable vaccine. These findings indicate that chloroplast-derived VLP vaccines may play a promising role in the prevention of various diseases, not only in fish but also in other animals, including humans.
Keywords: aquaculture; chloroplast genetic engineering; oral vaccine; red-spotted grouper nervous necrosis virus (RGNNV); virus-like particles (VLPs).
Copyright © 2021 Nakahira, Mizuno, Yamashita, Tsuchikura, Takeuchi, Shiina and Kawakami.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures







Similar articles
-
Protective immunity against nervous necrosis virus in convict grouper Epinephelus septemfasciatus following vaccination with virus-like particles produced in yeast Saccharomyces cerevisiae.Vet Microbiol. 2015 May 15;177(1-2):214-8. doi: 10.1016/j.vetmic.2015.02.021. Epub 2015 Feb 26. Vet Microbiol. 2015. PMID: 25759291
-
Oral vaccination through voluntary consumption of the convict grouper Epinephelus septemfasciatus with yeast producing the capsid protein of red-spotted grouper nervous necrosis virus.Vet Microbiol. 2017 May;204:159-164. doi: 10.1016/j.vetmic.2017.04.022. Epub 2017 Apr 24. Vet Microbiol. 2017. PMID: 28532796
-
Development of recombinant Yarrowia lipolytica producing virus-like particles of a fish nervous necrosis virus.J Microbiol. 2017 Aug;55(8):655-664. doi: 10.1007/s12275-017-7218-5. Epub 2017 Jul 28. J Microbiol. 2017. PMID: 28752293
-
Understanding the interaction between Betanodavirus and its host for the development of prophylactic measures for viral encephalopathy and retinopathy.Fish Shellfish Immunol. 2016 Jun;53:35-49. doi: 10.1016/j.fsi.2016.03.033. Epub 2016 Mar 17. Fish Shellfish Immunol. 2016. PMID: 26997200 Review.
-
Current status and future directions of fish vaccines employing virus-like particles.Fish Shellfish Immunol. 2020 May;100:49-57. doi: 10.1016/j.fsi.2020.02.060. Epub 2020 Mar 1. Fish Shellfish Immunol. 2020. PMID: 32130976 Review.
Cited by
-
Construction of Attenuated Strains for Red-Spotted Grouper Nervous Necrosis Virus (RGNNV) via Reverse Genetic System.Viruses. 2022 Aug 6;14(8):1737. doi: 10.3390/v14081737. Viruses. 2022. PMID: 36016359 Free PMC article.
-
Gut Immune System and the Implications of Oral-Administered Immunoprophylaxis in Finfish Aquaculture.Front Immunol. 2021 Dec 16;12:773193. doi: 10.3389/fimmu.2021.773193. eCollection 2021. Front Immunol. 2021. PMID: 34975860 Free PMC article. Review.
-
Oral Administration of Nanopeptide CMCS-20H Conspicuously Boosts Immunity and Precautionary Effect Against Bacterial Infection in Fish.Front Immunol. 2022 Jan 11;12:811616. doi: 10.3389/fimmu.2021.811616. eCollection 2021. Front Immunol. 2022. PMID: 35087530 Free PMC article.
-
Biotechnologically Engineered Plants.Biology (Basel). 2023 Apr 15;12(4):601. doi: 10.3390/biology12040601. Biology (Basel). 2023. PMID: 37106801 Free PMC article. Review.
-
An Introduction to Relevant Immunology Principles with Respect to Oral Vaccines in Aquaculture.Microorganisms. 2023 Dec 4;11(12):2917. doi: 10.3390/microorganisms11122917. Microorganisms. 2023. PMID: 38138061 Free PMC article. Review.
References
-
- Amend D. F. (1981). “Potency testing of fish vaccines,” in Fish Biologics: Serodiagnostics and Vaccines. Development in Biological Standardization. eds. Anderson D. P., Hennessen H. (Basel: Karger; ), 447–454.
LinkOut - more resources
Full Text Sources
Miscellaneous